COVID-19 studies:  C19 studies: C19:  IvermectinIVM Vitamin DV.D HC QHC Q Vitamin CV.C ZincZn BHBH FPVFPV FLVFLV PVP-IPI REGNR2 LY-CoVLY RMDRMD
Ivermectin study #7 of 65
8/14 Late treatment study
Bhattacharya et al., Int. J. Scientific Research, doi:10.36106/ijsr/7232245 (Peer Reviewed)
Observational Study on Clinical Features, Treatment and Outcome of COVID 19 in a tertiary care Centre in India- a retrospective case series
Source   PDF   Share   Tweet
Retrospective 148 hospitalized patients showing triple therapy with ivermectin + atorvastatin + N-acetylcysteine resulted in a 1.35% case fatality rate which was well below the national average.

Bhattacharya et al., 8/14/2020, peer-reviewed, mean age 57.6, 6 authors.
Details of all 65 studies    Meta analysis
Please send us corrections, updates, or comments.
Submit